These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10067041)

  • 1. Effect of dialysis on bleeding time in chronic renal failure.
    Butt ML; Shafi T; Farooqi I; Moinuddin
    J Pak Med Assoc; 1998 Aug; 48(8):242-4. PubMed ID: 10067041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?
    Bilen Y; Cankaya E; Keles M; Gulcan E; Uyanik A; Turkeli M; Albayrak B; Yildirim R
    Ren Fail; 2014 Feb; 36(1):69-72. PubMed ID: 24028675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep vein thrombosis in end-stage renal disease.
    Ifudu O; Delaney VB; Barth RH; Friedman EA
    ASAIO J; 1994; 40(1):103-5. PubMed ID: 8186484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet antiaggregation and hemorrhagic risk in hemodialysis].
    Sánchez Perales MC; Vázquez E; García Cortés MJ; Borrego FJ; Borrego J; Pérez del Barrio P; Liébana A; Gil JM; Viedma G; Pérez Bañasco V
    Nefrologia; 2002; 22(5):456-62. PubMed ID: 12497747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
    Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J
    Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
    Huraib S; al-Momen AK; Gader AM; Mitwalli A; Sulimani F; Abu-Aisha H
    Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet count may predict abnormal bleeding time among pregnant women with hypertension and preeclampsia.
    McDonagh RJ; Ray JG; Burrows RF; Burrows EA; Vermeulen MJ
    Can J Anaesth; 2001 Jun; 48(6):563-9. PubMed ID: 11444451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and associations for abnormal bleeding times in patients with renal insufficiency.
    Kim HY; Oak CY; Kim MJ; Kim CS; Choi JS; Bae EH; Ma SK; Kim SW
    Platelets; 2013; 24(3):213-8. PubMed ID: 22647149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet dysfunction and end-stage renal disease.
    Kaw D; Malhotra D
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.